AQRA 721
Latest Information Update: 27 Oct 1994
Price :
$50 *
At a glance
- Originator Boehringer Ingelheim
- Class Antiasthmatics; Bronchodilators
- Mechanism of Action Muscarinic M1 receptor antagonists; Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 17 Oct 1994 Discontinued-Preclinical for Asthma in Germany (PO)